Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Peptide analgesics described by Asahi Glass

Sep. 30, 1998

Neurotrophic/neuroprotective compounds claimed by Sanofi

Sep. 30, 1998

Guilford achieves development milestone in Amgen collaboration

Sep. 30, 1998

Sibia Neurosciences completes single-dose trial with SIB-1553A and initiates multiple-dose study

Sep. 29, 1998

JTP-2942 as a potential treatment for motor neuropathy

Sep. 29, 1998

Fetal neural transplantation may be a potential treatment for Huntington's disease

Sep. 29, 1998

Algos reports additional phase III data for MorphiDex

Sep. 28, 1998

Peripheral analgesics with excellent gastric tolerance claimed by ADIR

Sep. 28, 1998

UCB's anticonvulsant drug levetiracetam is safe and effective in phase III trials

Sep. 28, 1998

ZK-200775: a water-soluble AMPA antagonist with an excellent pharmacological profile

Sep. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...